Steven L. Krill, EVP & Chief Scientific Officer at EAGLE PHARMACEUTICALS, INC. (EGRX), sold 10,000 shares at $74.79 ($748K) on 2016-12-15, disclosed to the SEC on 2017-01-04.
Open-market sale of $748k EGRX by EVP & Chief Scientific Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $74.79 | 3,730 | $279K | 37.3% |
| 2 | $74.79 | 6,270 | $469K | 62.7% |
| Total | $74.79 avg | 10,000 | $748K | 100% |
| Filing → |
| EGRX | SELL | 2017-03-24 | $569K | — | Filing → |
| EGRX | SELL | 2017-01-04 | $756K | — | Filing → |
| EGRX | SELL | 2017-01-04 | $7.0M | — | Filing → |